Skip to main content

Table 1 Correlation between expression cyclin G2 and clinical Features in Gastric cancer

From: Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1

Clinicopathologic features

n

cyclin G2 expression

x2

P value

Up-regulate or no change

Down-regulate

Age(years)

 60 or younger

40

12

28

0.2209

0.6384

 Older than 60

49

17

32

Gender

 Male

67

21

46

0.1900

0.6629

 Female

22

8

14

Tumor size (cm3)

  ≤ 5

8

6

2

7.1991

0.0073

  > 5

81

23

58

Depth of tumor invasion

 T1-T2

23

9

14

0.6912

0.4057

 T3-T4

64

19

45

Histologic type

 Well and moderate

27

13

14

4.2739

0.0387

 Poor and undifferentiated

62

16

46

TNM stage

 I

15

7

8

7.1151

0.0683

 II

26

8

18

 III

38

8

30

 IV

10

6

4

Metastasis status

 No

79

23

56

3.8547

0.0496

 Yes

10

6

4

  1. NOTE. Cyclin G2 expression was up-regulated or unchanged in 29 gastric cancer tissues, down-regulated in 60 gastric cancer samples compared with the paired adjacent normal tissues. Both depth of tumor invasion and TNM stage: according to 2010 TNM classification of malignant tumors by the International Union Against Cancer. The statistical significance of the individuals was determined with x2 test
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us